NeuroPace Inc.

Mr. Gregory S. Garfield is an Independent Director at NeuroPace, Inc., a Senior Managing Director at Kck Us, Inc. and a Senior Managing Director at KCK Group LLC. He is on the Board of Directors at Earlens Corp., Cerapedics, Inc., NeuroPace, Inc., Mainstay Medical International Ltd., Aerin Medical, Inc., C2 Therapeutics, Inc., Mainstay Medical Holdings Plc, Reflexion Medical, Inc., Revent Medical, Inc., Rodo Medical, Inc., Sonex Health LLC, Sonitus Technologies, Inc., Mainstay Medical Ltd. and Greg & Dori Garfield Living Revocable Trust. Mr. Garfield was previously employed as an Independent Director by Semler Scientific, Inc., a Chief Operating Officer & General Counsel by Acclarent, Inc., a VP, General Counsel-Cardiac Surgery Group by Guidant Corp., a Vice President-New Business Development by Boston Scientific Corp., and an Attorney by Pillsbury Winthrop LLP. He also served on the board at Sonitus Medical, Inc. He received his undergraduate degree from California Polytechnic State University (San Luis Obispo) and a graduate degree from Mcgeorge School of Law.